KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Non-Current Liabilities (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Other Non-Current Liabilities data on record, last reported at $108.9 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 1.86% year-over-year to $108.9 million; the TTM value through Sep 2025 reached $108.9 million, down 1.86%, while the annual FY2024 figure was $86.6 million, 29.41% down from the prior year.
  • Other Non-Current Liabilities reached $108.9 million in Q3 2025 per JAZZ's latest filing, up from $93.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $144.0 million in Q4 2022 and bottomed at $86.6 million in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $116.3 million, with a median of $122.7 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: increased 17.74% in 2022, then fell 29.41% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $137.9 million in 2021, then grew by 4.43% to $144.0 million in 2022, then decreased by 14.78% to $122.7 million in 2023, then decreased by 29.41% to $86.6 million in 2024, then rose by 25.74% to $108.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $108.9 million in Q3 2025, $93.7 million in Q2 2025, and $91.1 million in Q1 2025.